Suven Life Sciences Share Price
Suven Life Sciences Ltd.
Today’s Low
Today’s High
52W Low
52W High
Open Price
Prev. Close
Volume
Value
Market Cap |
P/E Ratio |
P/B Ratio |
Industry P/E |
---|---|---|---|
Rs. 1036.29 Cr |
0.00 |
2.83 |
63.78 |
ROE |
EPS (TTM) |
Dividend Yield |
Book Value |
---|---|---|---|
-8.62 % |
-2.49 |
0.00 % |
39.34 |
All you have to do to buy Suven Life Sciences Ltd. share is download Nuuu app, create a demat account, and get your KYC documents verified online.
Yes you can buy Suven Life Sciences Ltd. shares, all you need is to have a verified demat account with Nuuu. And enjoy benefits like free brokerage credits and more.
As of 26 Mar`23 the Market Cap of Suven Life Sciences Ltd. is 1036.29.
As of 26 Mar`23 the PE is 0.00 and PB is 2.83.
Quarterly Results
Rights Issue inter alia,approved: 1.Approved the raising of funds, through issuance and allotment of equity shares having face value of Rs. 1 each up to an aggregate amount of Rs. 400 Crores (Rupees Four Hundred Crores) on rights basis and on such terms (as decided by the Board or a duly constituted committee of the Board, at a later date) to the eligible equity shareholders of the Company, as on the record date (to be notified subsequently), subject to receipt of regulatory/ statutory approvals, in accordance with the applicable laws including the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, SEBI LODR Regulations and the Companies Act, 2013, and rules and regulations made thereunder, each as amended from time to time and approved other related matters including the constitution of a Rights Issue Committee to implement the proposal of Rights Issue. 2.The Board of Directors has considered and approved increase in the Authorized Share Capital from Rs. 20 crores divided into 20 crores equity shares of Rs. 1/- each to Rs. 30 crores divided into 30 crores equity shares of Rs. 1/- each and consequential alteration in the Memorandum of Association of the Company, subject to the approval of shareholders of the Company.
Rights Issue & Inter alia, to consider matters related to raising of funds through issue of equity shares of the Company on rights basis to the existing equity shareholders of the Company in accordance with provisions of Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other matters related/ incidental thereto including the constitution of a Committee of Board of Directors namely ?Rights Issue Committee? to implement the proposal of Rights Issue.
Right Issue of Equity Shares
Rights Issue & Inter alia, to consider matters related to raising of funds through issue of equity shares of the Company on rights basis to the existing equity shareholders of the Company in accordance with provisions of Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended and other matters related/ incidental thereto including the constitution of a Committee of Board of Directors namely ?Rights Issue Committee? to implement the proposal of Rights Issue.
Audited Results
Quarterly Results
Quarterly Results